Form 4: Applied Therapeutics CFO Sells Shares to Cover Tax Obligations
SEC Form 4
Leslie D. Funtleyder, CFO of Applied Therapeutics, Inc., sold 16,980 shares of common stock on June 6, 2024, to cover tax withholding obligations related to the vesting and settlement of compensatory Restricted Stock Units.
Summary
- On June 6, 2024, Leslie D. Funtleyder, the Chief Financial Officer of Applied Therapeutics, Inc., sold 16,980 shares of the company's common stock.
- The shares were sold at a price of $4.32 per share.
- The sale was executed to cover tax withholding obligations associated with the vesting and settlement of compensatory Restricted Stock Units.
- Following the transaction, Funtleyder directly owns 291,441 shares of Applied Therapeutics, Inc.
- The sale was not a discretionary transaction but rather a 'sell to cover' transaction to satisfy tax obligations.
Sentiment
Score: 6
Explanation: The document reflects a neutral event (stock sale for tax obligations) with no inherent positive or negative implications for the company's overall prospects.
Industry Context
This is a routine transaction related to executive compensation and tax obligations, common in publicly traded companies.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 06/06/2024 | Date of the stock sale transaction. |
| 06/10/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.